Truist Financial’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $357K | Sell |
3,031
-641
| -17% | -$89.5K | ﹤0.01% | 2289 |
|
|
2025
Q4 | $602K | Buy |
3,672
+1,237
| +51% | +$194K | ﹤0.01% | 1942 |
|
|
2025
Q3 | $325K | Sell |
2,435
-717
| -23% | -$87.1K | ﹤0.01% | 2261 |
|
|
2025
Q2 | $392K | Sell |
3,152
-691
| -18% | -$87.9K | ﹤0.01% | 2070 |
|
|
2025
Q1 | $489K | Buy |
3,843
+890
| +30% | +$137K | ﹤0.01% | 1884 |
|
|
2024
Q4 | $425K | Sell |
2,953
-378
| -11% | -$54.2K | ﹤0.01% | 1972 |
|
|
2024
Q3 | $496K | Buy |
3,331
+664
| +25% | +$95.2K | ﹤0.01% | 1871 |
|
|
2024
Q2 | $336K | Sell |
2,667
-680
| -20% | -$107K | ﹤0.01% | 2233 |
|
|
2024
Q1 | $616K | Sell |
3,347
-903
| -21% | -$172K | ﹤0.01% | 1856 |
|
|
2023
Q4 | $764K | Buy |
4,250
+538
| +14% | +$83.7K | ﹤0.01% | 1744 |
|
|
2023
Q3 | $590K | Buy |
3,712
+300
| +9% | +$49K | ﹤0.01% | 1832 |
|
|
2023
Q2 | $483K | Buy |
3,412
+576
| +20% | +$92.4K | ﹤0.01% | 1966 |
|
|
2023
Q1 | $477K | Sell |
2,836
-1,997
| -41% | -$356K | ﹤0.01% | 2008 |
|
|
2022
Q4 | $818K | Sell |
4,833
-362
| -7% | -$65.7K | ﹤0.01% | 1651 |
|
|
2022
Q3 | $972K | Sell |
5,195
-171
| -3% | -$36.1K | ﹤0.01% | 1504 |
|
|
2022
Q2 | $871K | Sell |
5,366
-256
| -5% | -$40.5K | ﹤0.01% | 1620 |
|
|
2022
Q1 | $1.06M | Sell |
5,622
-1,256
| -18% | -$239K | ﹤0.01% | 1597 |
|
|
2021
Q4 | $1.82M | Sell |
6,878
-469
| -6% | -$126K | ﹤0.01% | 1340 |
|
|
2021
Q3 | $2.12M | Buy |
7,347
+1,336
| +22% | +$343K | ﹤0.01% | 1247 |
|
|
2021
Q2 | $1.2M | Buy |
6,011
+567
| +10% | +$110K | ﹤0.01% | 1534 |
|
|
2021
Q1 | $1.06M | Buy |
5,444
+152
| +3% | +$31.2K | ﹤0.01% | 1562 |
|
|
2020
Q4 | $1.01M | Buy |
5,292
+722
| +16% | +$131K | ﹤0.01% | 1470 |
|
|
2020
Q3 | $675K | Sell |
4,570
-315
| -6% | -$45K | ﹤0.01% | 1563 |
|
|
2020
Q2 | $605K | Sell |
4,885
-769
| -14% | -$90.5K | ﹤0.01% | 1525 |
|
|
2020
Q1 | $546K | Sell |
5,654
-285
| -5% | -$27.5K | ﹤0.01% | 1521 |
|
|
2019
Q4 | $549K | Buy |
5,939
+1,098
| +23% | +$92.2K | ﹤0.01% | 1796 |
|
|
2019
Q3 | $372K | Sell |
4,841
-1,564
| -24% | -$137K | 0.01% | 625 |
|
|
2019
Q2 | $550K | Sell |
6,405
-255
| -4% | -$17.4K | 0.01% | 561 |
|
|
2019
Q1 | $393K | Buy |
6,660
+75
| +1% | +$4.31K | 0.01% | 621 |
|
|
2018
Q4 | $347K | Sell |
6,585
-585
| -8% | -$34.3K | 0.01% | 616 |
|
|
2018
Q3 | $398K | Sell |
7,170
-415
| -5% | -$21.4K | 0.01% | 626 |
|
|
2018
Q2 | $357K | Sell |
7,585
-380
| -5% | -$15.6K | 0.01% | 646 |
|
|
2018
Q1 | $288K | Buy |
7,965
+120
| +2% | +$4.22K | 0.01% | 669 |
|
|
2017
Q4 | $285K | Sell |
7,845
-30
| -0.4% | -$1.09K | 0.01% | 688 |
|
|
2017
Q3 | $302K | Sell |
7,875
-185
| -2% | -$7.75K | 0.01% | 680 |
|
|
2017
Q2 | $334K | Sell |
8,060
-90
| -1% | -$3.42K | 0.01% | 642 |
|
|
2017
Q1 | $287K | Sell |
8,150
-415
| -5% | -$13.1K | 0.01% | 705 |
|
|
2016
Q4 | $264K | Sell |
8,565
-70
| -0.8% | -$2.17K | 0.01% | 732 |
|
|
2016
Q3 | $261K | Sell |
8,635
-180
| -2% | -$5.43K | 0.01% | 729 |
|
|
2016
Q2 | $241K | Buy |
+8,815
| New | +$225K | 0.01% | 756 |
|
Other funds holding RGEN
UCFA
VCM
VPM
MC
Truist Financial's RGEN Position: Q1 2026 in Review
Truist Financial reduced its Repligen (RGEN) stake by 17% in Q1 2026, selling an estimated $89.5K and leaving 3,031 shares worth $357K. The position accounts for ﹤0.01% of the portfolio, ranked #2289.
Truist Financial first reported a position in RGEN in Q2 2016 and has held it in 40 quarters since. The position peaked at $2.12M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Truist Financial held 3,031 shares of Repligen worth $357K as of Q1 2026.
- Truist Financial sold 641 Repligen shares in Q1 2026, an estimated $89.5K.
- Repligen made up ﹤0.01% of Truist Financial's portfolio in Q1 2026, its #2289 holding.
- Truist Financial first reported a position in Repligen in Q2 2016 and has held it in 40 quarters since.
- Truist Financial's Repligen position peaked at $2.12M in Q3 2021.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.